Find trials
Search tips

MYD88 Testing Validation on Fluid Specimens for for CNS and Vitreoretinal Lymphoma

Overview

About this study

The purpose of this study is to validate MYD88 testing in fluid specimens.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients with known or suspected CNS and/or vitreoretinal lymphoma.

Exclusion Criteria:

  • Patient unable to understand the consent for specimen collection or unwilling to participate.

Eligibility last updated 7/26/22. Questions regarding updates should be directed to the study team contact.

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Lauren Dalvin, M.D.

Open for enrollment

Contact information:

Lauren Dalvin M.D.

(507) 284-3721

Dalvin.Lauren@mayo.edu

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20566066

Mayo Clinic Footer